GlobeNewsWire
26 Jul 2026, 00:26 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
A securities fraud class action lawsuit has been filed against GRAIL, Inc. (NASDAQ: GRAL). — Lawsuits alleging fraud create significant legal liabilities and erode investor confidence in corporate governance.
-0.60GRAIL shares plummeted 50.55% on February 20, 2026, erasing over $2.2 billion in market capitalization following NHS-Galleri trial results. — A massive single-day drop suggests a fundamental failure in a key product or trial, indicating severe operational risk.
-0.50Investigations are focusing on whether GRAIL management misrepresented the required follow-up period for the NHS-Galleri trial. — Specific allegations of misleading data regarding trial durations suggest potential manipulation of clinical timelines to inflate stock price.
-0.40Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is facing a securities fraud class action lawsuit following a stock crash of over 50%.
The company's stock plunged due to allegedly misleading financial statements, triggering investor legal action.
The company's stock plunged due to allegedly misleading financial statements, triggering investor legal action.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
